Table 2.
Clinical characteristics of infected SARS-CoV-2 virus patients.
| No. Patient | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| Age y | 21 | 6 | 3.5 | 9 | 23 |
| BMI kg/m2 | 22.79 | 20.19 | 13.88 | 17.88 | 35.45 |
| Ambulation | no | yes | yes | yes | no |
| VS | 9 | 1 | 1 | 2 | 8 |
| BS | 6 | 1 | 1 | 2 | 5 |
| Comorbidities | Asperger syndrome | None | Celiac disease | Hypothyroidism | Cardio-myopathy |
| Steroid therapy | yes | Yes | yes | yes | Yes |
| ACE inhibitors | yes | Yes | yes | yes | Yes |
| Saturation NIV | 74% | 97% | 98% | 95% | 95% |
| no | no | no | no | no | |
| Source of COVID-19 infection | family | School | family | not known | Family |
| Clinical symptoms | fever | sore throat, headache, muscle pain, anosmia | fever | sore throat, muscle pain | anosmia |
| Complications | no | no | no | no | no |
| Infection date | Dec 2020 | Nov 2020 | Nov 2020 | Feb 2021 | Dec 2020 |
| Vaccination date | Jun 2021 | No | no | no | No |
| Family vaccination date | Jun 2021 | Jun 2021 | no | Jul 2021 | Oct 2021 |
| Family members at home (n) | 4 | 5 | 4 | 6 | 4 |
BMI, body mass index; VS, Vignos scale; BS, Brook scale; NIV, non-invasive ventilation.